Clinical Trials Browser

Has results × Zoledronic Acid × Breast × Clear all

NCT00295646 2024-03-15

Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid

Phase 3 Completed

1,803 enrolled 20 charts

Breast Neoplasms

NCT00556374 2023-07-27

Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy

Phase 3 Completed

3,420 enrolled 19 charts

Breast Neoplasms

NCT00321464 2022-11-08

A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.

Phase 3 Completed

2,049 enrolled 16 charts

Breast Neoplasms, Fractures, Bone

NCT00566618 2022-02-25

Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone Metastasis

Phase 1/2 Completed

31 enrolled 8 charts

Breast Neoplasms

NCT00127205 2021-07-02

S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.

Phase 3 Completed

6,097 enrolled 20 charts

Breast Neoplasms

NCT00295867 2020-05-12

Zoledronate in Treating Bone Marrow Micrometastases in Women With Stage I, Stage II, or Stage III Breast Cancer

Phase 2 Completed

45 enrolled 9 charts

Breast Neoplasms

NCT01409811 2020-05-08

Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic Acid

Phase NA Terminated

9 enrolled 3 charts

Breast Neoplasms, Carcinoma, Ductal, Breast

NCT00305695 2020-03-24

Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries

Phase 2 Completed

160 enrolled 10 charts

BreastGynecologic

Osteoporosis, Ovarian Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

NCT00213980 2019-11-27

Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer

Phase 2 Completed

68 enrolled 11 charts

Breast Neoplasms

NCT00436917 2019-09-11

Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast Cancer

Phase NA Completed

60 enrolled 23 charts

Breast Neoplasms, Osteoporosis

NCT00869206 2018-11-07

Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement

Phase 3 Completed

1,822 enrolled 19 charts

BreastGenitourinaryPlasma cell

Breast Neoplasms, Multiple Myeloma, Pain, Prostatic Neoplasms

NCT01194440 2018-09-12

Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms

Phase 2 Completed

63 enrolled 7 charts

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00399802 2018-08-16

A Study to Examine the Effects of an Experimental Drug on Women With Breast Cancer and Metastatic Bone Disease (MBD)(0822-016)(COMPLETED)

Phase 2 Completed

43 enrolled 10 charts

Bone Diseases, Breast Neoplasms

NCT00903162 2016-04-18

Extended Endocrine Therapy for Premenopausal Women With Breast Cancer

Phase 2 Completed

17 enrolled 5 charts

Breast Neoplasms

NCT00375505 2015-09-07

The Safety and Efficacy of Zoledronic Acid in the Prevention of Cancer Therapy Induced Bone Loss

Phase 3 Completed

70 enrolled 25 charts

Breast Neoplasms

NCT00333229 2014-11-25

A Study of Zoledronic Acid in the Prevention of Cancer Therapy-induced Bone Loss

Phase 4 Terminated

11 enrolled 6 charts

Breast Neoplasms

NCT00320710 2014-08-22

Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer

Phase 3 Completed

416 enrolled 10 charts

Breast Neoplasms

NCT00712985 2014-04-24

CTIBL

Phase 3 Completed

18 enrolled 5 charts

Breast Neoplasms

NCT00171340 2012-04-16

Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.

Phase 3 Completed

1,065 enrolled 10 charts

Bone Diseases, Metabolic, Breast Neoplasms

NCT00171314 2012-04-11

The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer

Phase 3 Completed

527 enrolled 11 charts

Breast Neoplasms

NCT00375427 2012-04-11

Safety and Efficacy of Zoledronic Acid in Patients With Breast Cancer With Metastatic Bone Lesions

Phase 3 Completed

430 enrolled 12 charts

Breast Neoplasms

NCT00332709 2011-11-16

Safety/Efficacy of Letrozole Monotherapy or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer

Phase 3 Completed

83 enrolled 14 charts

Breast Neoplasms, Osteoporosis